Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions

OBJECTIVES: High dose of intravenous sulfamethoxazole and trimethoprim (co-trimoxazole) is often used in immunocompromised patients for the treatment of Pneumocystis jiroveci pneumonia. Current manufacturer’s dilution recommendation for intravenous co-trimoxazole (1:25 v/v) requires the administrati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Khaleel, Israa, Zaidi, Syed Tabish R, Shastri, Madhur D, Eapen, Mathew Suji, Ming, Long Chiau, Wanandy, Troy, Patel, Rahul P
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319416/
https://ncbi.nlm.nih.gov/pubmed/31157078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2017-001225
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars